Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients
Statin use was associated with increased rates of diabetes in overweight and obese patients.
Investigators sought to determine an association between diabetes and HbA1C with postoperative outcomes.
Overall, once-weekly semaglutide 1.0 mg as an add-on to basal insulin is the most efficacious GLP-1 receptor agonist in terms of reductions in HbA1c and body weight from baseline after ...
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.